BioCryst Pharmaceuticals, Inc. (BCRX)

9.58 +0.56 (+6.21%) USD  |  NASDAQ  |  Apr 06, 11:59
More

BioCryst Pharmaceuticals SG&A Expense (Semi Annual)

SG&A Expense (Semi Annual) Chart

View SG&A Expense (Semi Annual) for BCRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Semi Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Semi Annual) Range, Past 5 Years

View SG&A Expense (Semi Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Semi Annual) Benchmarks

View SG&A Expense (Semi Annual) Benchmarks
Start Trial
Anika Therapeutics, Inc. --
Lantheus Holdings, Inc. --
Revolution Medicines, Inc. --
Plus Therapeutics, Inc. --
BioStem Technologies, Inc. --
Register to Continue Using YCharts

Access quality data, powerful visualization tools, and advanced analytics to make smarter investment decisions.

Unlock My Access No credit card required.

Already a subscriber? Sign in.